Molnupiravir Extends COVID-19 Viral Phase, Evidenced by the High Frequency of Rare and Dangerous Mutations in SARS-COV-2, preprint, 2021-12-20 Unexpected Mildness of Host-Induced Mutations in SARS-COV-2, preprint v2, (v1, 2021-12-08) Treating a Pandemic Respiratory Disease with a Mutagen is a Doomsday Scenario, preprint, 2021-12-02 AMDAC used the decision-making process in authorization of Remdesivir (Remdeathivir) as … Continue reading Molnupiravir Armageddon